Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment

S. Terrisse, L. Derosa, V. Iebba, F. Ghiringhelli, I. Vaz-Luis, G. Kroemer, M. Fidelle, S. Christodoulidis, N. Segata, A.M. Thomas, A.L. Martin, A. Sirven, S. Everhard, F. Aprahamian, N. Nirmalathasan, R. Aarnoutse, M. Smidt, J. Ziemons, C. Caldas, S. LoiblC. Denkert, S. Durand, C. Iglesias, F. Pietrantonio, B. Routy, F. Andre, E. Pasolli, S. Delaloge, L. Zitvogel*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Web of Science)
Original languageEnglish
Pages (from-to)2778-2796
Number of pages19
JournalCell Death and Differentiation
Volume28
Issue number9
DOIs
Publication statusPublished - 1 Sep 2021

Keywords

  • TUMOR-INFILTRATING LYMPHOCYTES
  • STANDARDIZED METHOD
  • GUT MICROBIOME
  • SOLID TUMORS
  • ADENOSINE
  • IMMUNOTHERAPY
  • EFFICACY
  • THERAPY
  • PATHOLOGISTS
  • CARCINOMA

Cite this